Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
58 NC counties are under alert, including Orange and Northampton counties.
Program
On WRAL at 6: Kitchen staff dressed as patient caregivers during hospital inspections
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ovid Therapeutics Inc
(NQ:
OVID
)
1.045
+0.035 (+3.47%)
Streaming Delayed Price
Updated: 12:50 PM EDT, Jul 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
143,593
Open
1.030
Bid (Size)
1.040 (2)
Ask (Size)
1.050 (11)
Prev. Close
1.010
Today's Range
1.000 - 1.060
52wk Range
0.6800 - 4.139
Shares Outstanding
70,417,345
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists
July 23, 2024
Group to Advise on the Application of Ovid’s Novel Pipeline Programs to Broader Disorders of the Brain
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
7 Sorry Biotech Stocks Set to Make Investors Sad
July 22, 2024
Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell.
Via
InvestorPlace
Performance
YTD
-68.52%
-68.52%
1 Month
+32.28%
+32.28%
3 Month
-66.83%
-66.83%
6 Month
-70.48%
-70.48%
1 Year
-70.14%
-70.14%
More News
Read More
eNeuro Publishes Findings on the Anti-Convulsant Properties of OV329 and Its Potential Effectiveness in Treatment-Resistant Seizures
July 10, 2024
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Evaluating Ovid Therapeutics: Insights From 6 Financial Analysts
June 18, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Ovid Therapeutics
May 07, 2024
Via
Benzinga
Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations
July 01, 2024
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Nasdaq Surges Over 200 Points; Aaron's Shares Jump
June 17, 2024
Via
Benzinga
Is the Stock Market Closed on Juneteenth 2024?
June 17, 2024
Via
InvestorPlace
ACHR Stock Alert: Archer Aviation Strikes New Deal With Signature Aviation
June 17, 2024
Via
InvestorPlace
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 17, 2024
Via
Benzinga
AAN Stock Alert: The Aaron’s Company Pops 33% on Take-Private Deal
June 17, 2024
Via
InvestorPlace
Why Is Ovid Therapeutics (OVID) Stock Down 69% Today?
June 17, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
June 17, 2024
Via
Benzinga
Crude Oil Rises 1%; Mustang Bio Shares Spike Higher
June 17, 2024
Via
Benzinga
Exposures
Fossil Fuels
US Stocks Mixed; Dow Tumbles Over 100 Points
June 17, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail?
June 17, 2024
Via
Benzinga
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
June 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 17, 2024
Via
Benzinga
Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlestat
June 17, 2024
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
3 Sorry Penny Stocks to Sell in May While You Still Can
May 28, 2024
Via
InvestorPlace
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for May 2024
May 20, 2024
Via
InvestorPlace
OVID Stock Earnings: Ovid Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 14, 2024
Via
InvestorPlace
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
May 14, 2024
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
May 13, 2024
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 24, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.